S

Sun Pharma Advanced Research Co Ltd
NSE:SPARC

Watchlist Manager
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Watchlist
Price: 161.03 INR -0.24% Market Closed
Market Cap: 52.3B INR

Relative Value

The Relative Value of one SPARC stock under the Base Case scenario is 8.41 INR. Compared to the current market price of 161.03 INR, Sun Pharma Advanced Research Co Ltd is Overvalued by 95%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SPARC Relative Value
Base Case
8.41 INR
Overvaluation 95%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
30
vs Industry
4
Median 3Y
59.7
Median 5Y
47.2
Industry
2.6
Forward
0.1
vs History
vs Industry
Median 3Y
-25.2
Median 5Y
-26.6
Industry
22.2
Forward
2.8
vs History
vs Industry
Median 3Y
-29.2
Median 5Y
-29.3
Industry
17.2
vs History
vs Industry
Median 3Y
-27.2
Median 5Y
-27.1
Industry
23.7
vs History
vs Industry
1
Median 3Y
12.3
Median 5Y
-21.9
Industry
2.2
vs History
30
vs Industry
3
Median 3Y
61.1
Median 5Y
48.5
Industry
2.8
Forward
0.1
vs History
28
vs Industry
1
Median 3Y
102.7
Median 5Y
58.1
Industry
5.4
vs History
vs Industry
Median 3Y
-26.5
Median 5Y
-28.2
Industry
13.3
Forward
0.3
vs History
vs Industry
Median 3Y
-25.4
Median 5Y
-26.8
Industry
16.8
Forward
0.4
vs History
vs Industry
Median 3Y
-29.2
Median 5Y
-30.2
Industry
15.6
vs History
vs Industry
Median 3Y
-25.3
Median 5Y
-27.2
Industry
18.1
vs History
87
vs Industry
3
Median 3Y
36.2
Median 5Y
44.1
Industry
2

Multiples Across Competitors

SPARC Competitors Multiples
Sun Pharma Advanced Research Co Ltd Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
52.3B INR 72.8 -15.3 -17 -16.4
US
Eli Lilly and Co
NYSE:LLY
731.4B USD 14.9 65.9 35.4 38.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
393.8B USD 4.3 17.4 13.3 17.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK 6.1 17.6 12.2 14
CH
Roche Holding AG
SIX:ROG
205.6B CHF 3.4 24.8 9.3 10.9
CH
Novartis AG
SIX:NOVN
180.8B CHF 4.2 17.5 10.4 13.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 3.9 27.5 130.5 196.8
US
Merck & Co Inc
NYSE:MRK
201.2B USD 3.1 11.5 8.6 10.4
IE
Endo International PLC
LSE:0Y5F
183.8B USD 79.3 -62.9 292.4 733.2
US
Pfizer Inc
NYSE:PFE
139.1B USD 2.2 17.6 7.6 10.6
P/E Multiple
Earnings Growth PEG
IN
S
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Average P/E: 25
Negative Multiple: -15.3
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
65.9
49%
1.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.4
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
17.6
18%
1
CH
Roche Holding AG
SIX:ROG
24.8
32%
0.8
CH
Novartis AG
SIX:NOVN
17.5
17%
1
UK
AstraZeneca PLC
LSE:AZN
27.5
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.5
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -62.9 N/A N/A
US
Pfizer Inc
NYSE:PFE
17.6
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
S
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Average EV/EBITDA: 436.6
Negative Multiple: -17
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.4
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
13.3
7%
1.9
DK
Novo Nordisk A/S
CSE:NOVO B
12.2
13%
0.9
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.4
5%
2.1
UK
AstraZeneca PLC
LSE:AZN
130.5
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.6
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
292.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
2%
3.8
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IN
S
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Average EV/EBIT: 1 874.8
Negative Multiple: -16.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
38.7
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
17.4
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14
14%
1
CH
Roche Holding AG
SIX:ROG
10.9
6%
1.8
CH
Novartis AG
SIX:NOVN
13.9
10%
1.4
UK
AstraZeneca PLC
LSE:AZN
196.8
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.4
11%
0.9
IE
E
Endo International PLC
LSE:0Y5F
733.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.6
10%
1.1